The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Eigerbio Europe LimitedEU/1/22/1660/002

Main Information

Trade NameZokinvy
Active SubstancesLonafarnib
Dosage FormCapsule, hard
Licence HolderEigerbio Europe Limited
Licence NumberEU/1/22/1660/002

Group Information

ATC CodeA16AX20 Lonafarnib


License statusAuthorised
Licence Issued18/07/2022
Legal status*** AWAITING VALUE ***
Supply Status
Advertising Status*** AWAITING VALUE ***
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back